A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Clinical trial NCT03594123 · COMPLETED
Trial details
- NCT number
- NCT03594123
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2022-09-19
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.